PTC
SGTX

Philadelphia Trust Company’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Philadelphia Trust Company’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,462
Closed -$483K – 249
2021
Q2 		$483K Sell
3,462
-2,762
-44% -$385K 0.03% 178
2021
Q1 		$1.81M Buy
6,224
+5,174
+493% +$1.5M 0.14% 100
2020
Q4 		$655K Buy
+1,050
New +$655K 0.05% 140